Full-Time
Business Development Associate
Confirmed live in the last 24 hours
Ganymede
51-200 employees
Cloud platform for scientific data management
Compensation Overview
$60k - $90kAnnually
Entry, Junior
Remote in USA
Willing to relocate, or currently in, the greater Boston (MA) metro area. Ability to travel 20-30% time preferred.
You match the following Ganymede's candidate preferences
Employers are more likely to interview you if you match these preferences:
- Minimum of a bachelor’s degree, with strong preference for a graduate degree in STEM or an MBA.
- 2+ years of prior experience either working at a biotech or in sales for a highly technical product (i.e. enterprise software).
- Hunger, curiosity, and motivation to learn about and solve data problems for clients with the rest of the Ganymede team.
- Integrity, ability to self-start, creativity, and compassionate courage when faced with adversity.
- Excellent oral and written communication skills.
- Willingness and interest to travel as needed to client sites and conferences across the country.
- Willing to relocate, or currently in, the greater Boston (MA) metro area.
- Spearhead efforts to source new clients and build out the sales strategy.
- Become an expert at recognizing who the platform can help and why.
- Evangelize the benefits of well-designed software in biotech.
- Carefully source and cultivate deep relationships with potential clients.
- Work closely with the founders to close sales and ensure customer success with the PaaS.
- Travel to conferences and client sites to build in-person relationships and understand scientists’ workflows.
- Ability to travel 20-30% time preferred.
Ganymede.bio provides a cloud-based platform that focuses on managing scientific data and connecting laboratory instruments. The platform helps scientists save time by automating data management, allowing them to focus more on their research. It integrates various lab instruments and applications into a single data layer, which reduces the need for manual data entry and file management. Ganymede's unique Lab-as-Code technology enables this automation, producing compliant data suitable for artificial intelligence and machine learning applications. Unlike its competitors, Ganymede's platform can connect to any instrument or application, transforming data into a cloud-based format that is ready for analysis. The goal of Ganymede is to modernize data management systems in the scientific and research industry, ensuring that all data is FAIR (Findable, Accessible, Interoperable, and Reusable) and providing features for data compliance, including context, traceability, and versioning.
Company Size
51-200
Company Stage
Series A
Total Funding
$15.2M
Headquarters
Palo Alto, California
Founded
2022
Simplify's Take
What believers are saying
- Partnerships with Elemental Machines and Kytopen expand Ganymede's market reach.
- Rising demand for low-code platforms aligns with Ganymede's offerings.
- Ganymede's platform supports AI and machine learning, enhancing scientific research capabilities.
What critics are saying
- Increased competition from established biotech software players could challenge Ganymede's market position.
- Rapid AI advancements may outpace Ganymede's current offerings, requiring continuous innovation.
- Data privacy concerns and regulatory scrutiny could arise with expanded data integration services.
What makes Ganymede unique
- Ganymede offers a low-code bio-aware PaaS for biotech software engineering.
- Their Lab-as-Code technology automates data management, saving scientists up to 20% time.
- Ganymede ensures data is FAIR, enhancing findability, accessibility, interoperability, and reusability.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote-first role
Periodic reimbursed travel for the team to meet together
Significant equity as an early employee
Unlimited PTO & sick days
Excellent health benefits (medical, dental & vision), life, and disability insurance
Family leave (maternity, paternity, medical, caregiver)
Growth & Insights and Company News
6 month growth
↑ 12%1 year growth
↑ 7%2 year growth
↑ 12%Ganymede Bio launches industry-first gxp-native developer platform and data infrastructure for wet lab data.
Elemental Machines, developer of the Intelligent Operations Platform, has entered into a partnership with Ganymede Bio, the cloud infrastructure provider purpose-built for the life sciences and manufacturing industries, to extend the digital range of life sciences operators.
CAMBRIDGE, Mass. , Oct. 3, 2023 /PRNewswire/ -- Elemental Machines, developer of the Intelligent Operations Platform, has entered into a partnership with Ganymede Bio, the cloud infrastructure provider purpose-built for the life sciences and manufacturing industries, to extend the digital range of life sciences operators.The partnership will allow Elemental Machines and Ganymede to better serve laboratory and manufacturing professionals with increased connectivity and access to data in a single digital platform. The combination of Elemental Machines' hardware and environmental data with Ganymede's analytical and scientific data enables users to view a more complete picture of their facilities both at a scientific and operational level.Ganymede's Lab-as-Code scientific data and instrument integration platform unites everything from analytical instrument data to laboratory information management systems (LIMS) and more in a single FAIR cloud. The company's off-the-shelf instrument and app connectors and data automation systems can automate scientific analysis and produce powerful visualizations for data in the lab, automatically pulling data entry into electronic laboratory notebooks (ELNs) or LIMS. With Ganymede, scientists save as much as 20 percent of their time by eliminating manual data tasks and organizations are empowered to more easily build a rich data lake for IT and data science teams.Elemental Machines' unique Intelligent Operations Platform is comprised of Internet of Things (IoT) hardware and software that offers real-time and historical monitoring data of essential equipment and environmental factors
One of the many reasons Ganymede is so excited to be partnering with Kytopen has to do with how original equipment manufacturers (OEMs) approach data.
The companies have signed an agreement to integrate Ganymede's cloud platform with Kytopen's FlowFect® cell therapy screening and manufacturing instruments.
Ganymede Bio, the cloud infrastructure provider purpose-built for the life sciences and manufacturing industries, today announced a $12.75 million Ser
Ganymede Bio, the cloud infrastructure provider purpose-built for the life sciences and manufacturing industries, today announced a $12.75 million Series A funding round, led by Caffeinated Capital.
PALO ALTO, Calif.--(BUSINESS WIRE)--Ganymede Bio, the cloud infrastructure provider purpose-built for the life sciences and manufacturing industries, today announced a $12.75 million Series A funding round, led by Caffeinated Capital. This follows a $2.9 million seed round completed earlier this year, bringing the total to over $15.6 million. Founded in 2022, the company has exceeded $1 million in revenue commitments, with clients ranging from early-stage biotechs to large, established biopharmaceutical companies.“Scientific software, especially for biotechs, is 10 to 20 years behind other industries,” said Nathan Clark, co-founder of Ganymede Bio. “We have built a platform that allows rapid coding integrations between instruments and apps like LIMS or MES, generates a singular data lake in a harmonized format, and fits modularly into any client tech stack—integrating natively with existing clouds in AWS or GCP or Azure. This makes data and operations visible to management and analysis-ready for machine learning or digital twins.”Ganymede’s data platform is powered by its revolutionary Lab-as-Code core technology. It enables scientists and bioinformaticians to write their own real-time integrations and scientific analysis in a low-code cloud IDE by directly connecting to any lab instrument or scientific software, ultimately bringing entire labs and manufacturing sites onto the cloud—and fast